Advertisement
Screener

GAIN THERAPEUTICS, INC (GANX) Total Assets

GAIN THERAPEUTICS, INC Total Assets

GAIN THERAPEUTICS, INC (GANX) had Total Assets of $15.42 million as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Assets

us-gaap:Assets · last filed 2026-08-11

  • 2026-06-30: Assets $15.42M.
  • 2026-03-31: Assets $18.74M.
  • 2025-12-31: Assets $22.82M.
  • 2025-09-30: Assets $10.97M.
Period endAssets
2026-06-30$15.42M
10-Q · filed 2026-08-11
2026-03-31$18.74M
10-Q · filed 2026-05-11
2025-12-31$22.82M
10-Q · filed 2026-08-11
2025-09-30$10.97M
10-Q · filed 2025-11-12
2025-06-30$9.83M
10-Q · filed 2025-08-12
2025-03-31$11.62M
10-Q · filed 2025-05-14
2024-12-31$12.12M
10-K · filed 2026-03-26
2024-09-30$14.37M
10-Q · filed 2024-11-14
2024-06-30$19.20M
10-Q · filed 2024-08-08
2024-03-31$14.58M
10-Q · filed 2024-05-14
2023-12-31$18.61M
10-K · filed 2025-03-27
2023-09-30$14.10M
10-Q · filed 2023-11-14
2023-06-30$18.26M
10-Q · filed 2023-08-10
2023-03-31$21.32M
10-Q · filed 2023-05-12
2022-12-31$24.10M
10-K · filed 2024-03-26
2022-09-30$28.33M
10-Q · filed 2022-11-10
2022-06-30$31.89M
10-Q · filed 2022-08-08
2022-03-31$37.60M
10-Q · filed 2022-05-16
2021-12-31$38.99M
10-K · filed 2023-03-23
2021-09-30$42.56M
10-Q · filed 2021-11-12
2021-06-30$45.35M
10-Q · filed 2021-08-12
2021-03-31$48.04M
10-Q · filed 2021-05-10
2020-12-31$9.60M
10-K · filed 2022-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B